近日，公司全资子公司青岛瑜阳体育科技有限公司（以下简称"瑜阳体 育"）与交通银行股份有限公司青岛分行（以下简称"交通银行青岛分行"） 签订《流动资金借款合同》，瑜阳体育向交通银行青岛分行申请不超过1,000万 元人民币综合授信额度；公司与交通银行青岛分行签署《保证合同》，为瑜阳 1 证券代码：001300 证券简称：三柏硕 公告编号：2025-033 青岛三柏硕健康科技股份有限公司 关于全资子公司向银行申请授信额度并由公司为其提供担 保的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 一、授信额度及担保情况概述 青岛三柏硕健康科技股份有限公司（以下简称"公司"）于2025年4月25日 分别召开第二届董事会第八次会议、第二届监事会第八次会议，于2025年5月20 日召开2024年年度股东大会，审议通过了《关于2025年度向银行等金融机构申 请授信额度及担保事项的议案》，同意2025年度公司及全资子公司拟向银行等 金融机构申请额度不超过人民币8亿元的综合授信。在上述授信总额额度内，公 司将根据实际需要由公司及全资子公司以其拥有的资产为其自身融资提供抵押、 质 ...

Core Viewpoint - Qingdao Sanbai Shuo Health Technology Co., Ltd. announced its 2024 annual equity distribution plan, which includes a cash dividend of 0.10 yuan per 10 shares for all shareholders, totaling 2,424,809.14 yuan, with specific conditions regarding share repurchase and tax implications [2][4][6]. Group 1: Equity Distribution Details - The total share capital of the company is 243,775,914 shares, from which 1,295,000 shares held in the repurchase account are excluded, resulting in a base of 242,480,914 shares for the dividend distribution [2][6]. - The cash dividend of 0.10 yuan per 10 shares is inclusive of tax, and the total cash dividend amount is fixed at 2,424,809.14 yuan, with no stock dividends or capital increases from reserves [2][4]. - The dividend distribution plan was approved at the 2024 annual general meeting held on May 20, 2025, and the implementation will occur on June 26, 2025, following the record date of June 25, 2025 [7][8][13]. Group 2: Tax Implications and Payment Method - Different tax rates apply for various categories of shareholders, with specific provisions for Hong Kong investors and domestic investors based on their holding periods [6][10]. - Cash dividends will be directly credited to shareholders' accounts through their custodial securities companies on the payment date [9][10]. - The company assumes all legal responsibilities for any discrepancies in dividend payments due to changes in shareholder accounts during the distribution application period [10]. Group 3: Adjustments and Compliance - The minimum selling price restrictions for major shareholders will be adjusted in accordance with the equity distribution, ensuring compliance with regulatory requirements [11]. - The reference price for ex-dividend trading will be calculated based on the closing price on the record date minus the dividend amount per share [12].

关于通过全资子公司向控股孙公司增加投资的公告 证券代码：001300 证券简称：三柏硕 公告编号：2025-031 青岛三柏硕健康科技股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 青岛三柏硕健康科技股份有限公司（以下简称"公司"）于2025年6月17日 召开第二届董事会第九次会议，审议通过了《关于通过全资子公司向控股孙公司 增加投资的议案》，同意公司以自有资金和自筹资金通过全资子公司OCEAN MASTER INVESTMENTS,INC（以下简称"海硕投资"）向公司控股孙公司三柏硕健 康科技（越南）有限公司（Sportsoul Health Technology (Vietnam) Co.,Ltd） （以下简称"越南三柏硕"）增加投资，现将具体情况公告如下： 一、本次投资情况概述 越南三柏硕系公司控股孙公司，由公司全资子公司海硕投资与CYVERCE LLC （中文译名：塞沃斯公司，以下简称"塞沃斯"）于2025年2月在越南共同出资 设立，注册资本108万美元，其中，海硕投资出资64.80万美元，持股比例60%， 塞沃斯出资43.20万美元，持 ...

青岛三柏硕健康科技股份有限公司 第二届董事会第九次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 青岛三柏硕健康科技股份有限公司（以下简称"公司"）第二届董事会第九 次会议于 2025 年 6 月 17 日以现场和通讯方式召开，会议通知于 2025 年 6 月 13 日以通讯方式送达。经全体董事一致同意豁免本次董事会会议通知时限。会议应 出席董事 7 名，实际出席董事 7 名。公司董事长朱希龙先生主持本次会议。会议 的召集、召开符合《中华人民共和国公司法》等法律法规及《青岛三柏硕健康科 技股份有限公司章程》的规定。公司监事、高级管理人员列席本次会议。 与会董事对本次会议的全部议案进行了充分讨论，审慎表决，形成如下决议： 一、审议通过：《关于通过全资子公司向控股孙公司增加投资的议案》 证券代码：001300 证券简称：三柏硕 公告编号：2025-030 表决情况：7票同意，0票反对，0票弃权。 具体内容详见公司同日刊登在《证券时报》《证券日报》《中国证券报》《上 海证券报》《经济参考报》和巨潮资讯网（www.cninfo.com.cn）的《关于通过 ...

公司2024年年度权益分派方案已获2025年5月20日召开的2024年度股东大会 审议通过。现将权益分派事宜公告如下： 一、股东大会审议通过利润分配方案情况 1、公司2024年度股东大会审议通过的2024年度利润分配预案为：以公司2024 年12月31日公司总股本243,775,914股扣除公司回购专用证券账户上已回购股份 1,295,000股后的总股本242,480,914股为基数，向全体股东每10股派发现金股利 0.10元（含税），共计分配现金红利2,424,809.14元，不送红股，不以公积金转增 股本。如在利润分配预案公告后至实施前，因新增股份上市、股份回购等事项导 致公司总股本发生变化的,公司拟按照现金分红总额固定不变的原则对分配比例 进行相应的调整。 证券代码：001300 证券简称：三柏硕 公告编号：2025-032 青岛三柏硕健康科技股份有限公司 2024 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 根据《深圳证券交易所上市公司自律监管指引第9号-回购股份》的相关规定， 青岛三柏硕健康科技股份有限公司（以 ...

Core Points - The company held its second board meeting on June 17, 2025, with all seven directors present, and the meeting complied with relevant laws and regulations [1][2] - The board unanimously approved the proposal for the wholly-owned subsidiary to increase investment in the controlling subsidiary, with a voting result of 7 votes in favor, 0 against, and 0 abstentions [1][2] - The details of the investment proposal are available in the company's announcement published on various financial news platforms [1]

Core Insights - The company is adapting to changing international trade conditions, particularly U.S. tariff policies, which have impacted its export operations and prompted a shift towards a dual supply system with domestic and overseas bases [2][3][4] - The company has made strategic investments in localizing its brand in North America, including a $13 million acquisition of a U.S. firm, which has allowed it to develop products that meet local standards and reduce reliance on cross-border e-commerce platforms [3][4] - The company is expanding its product offerings to include rehabilitation equipment and smart classroom furniture, targeting the domestic silver economy and education equipment markets [4][5] Group 1 - The company has resumed order flow after a period of stagnation due to tariff adjustments, with new orders exceeding 1 million yuan [2] - The establishment of a factory in Vietnam is part of the company's strategy to mitigate tariff risks and enhance its Southeast Asian market presence [2][3] - The company is transitioning from an OEM model to an ODM model, focusing on original design manufacturing to create a "second growth curve" [2][4] Group 2 - The company has invested at least 3% of its revenue annually in R&D, resulting in 205 global patents, which enhances its competitive edge [5] - The introduction of AI-driven products, such as the "SHOTLAB intelligent basketball training ground," demonstrates the company's commitment to technological innovation [4][5] - The company is leveraging its advanced manufacturing capabilities to maintain high precision in its products, which is crucial for its reputation as a leading supplier [5]

证券代码：001300 证券简称：三柏硕 公告编号：2025-029 青岛三柏硕健康科技股份有限公司 2024年年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1．本次股东大会未出现否决、修改、增加议案的情形。 2．本次股东大会未涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 1. 召开时间： （1）现场会议时间：2025 年 5 月 20 日下午 14:00。 （2）网络投票时间：2025 年 5 月 20 日。其中，通过深圳证券交易所交易 系统进行网络投票的具体时间为：2025 年 5 月 20 日上午 9:15-9:25、9:30-11:30， 下午 13:00-15:00；通过深圳证券交易所互联网投票系统投票的具体时间为： 2025 年 5 月 20 日上午 9:15-下午 15:00 期间任意时间。 2. 现场会议召开地点：山东省青岛市城阳区荣海二路 3 号公司办公楼会议 室。 3. 召开方式：本次股东大会采用现场投票与网络投票相结合的方式。 （1）现场投票：现场出席及通过填写授权委托书授权他人出席。 （ ...

北京市中伦（青岛）律师事务所 关于青岛三柏硕健康科技股份有限公司 2024 年年度股东大会的 法律意见书 二〇二五年五月 北京 •上海 •深圳 •广州 •成都 •武汉 •重庆 •青岛 •杭州 •香港 •东京 •伦敦 •纽约 •洛杉矶 •旧金山 Beijing • Shanghai • Shenzhen • Guangzhou • Chengdu • Wuhan • Chongqing • Qingdao • Hangzhou • Hong Kong • Tokyo • London • New York •Los Angeles• San Francisco 北京市中伦（青岛）律师事务所 关于青岛三柏硕健康科技股份有限公司 2024 年年度股东大会的 法律意见书 致：青岛三柏硕健康科技股份有限公司 北京市中伦（青岛）律师事务所（以下简称"本所"）接受青岛三柏硕健康科 技股份有限公司（以下简称"公司"）的委托，根据本法律意见书出具日前已经发 生或存在的事实和《中华人民共和国公司法》（以下简称"《公司法》"）、《中 华人民共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》 《律师事务所从事证券法律业 ...

Core Insights - The company is experiencing a recovery in order flow, with recent adjustments in tariff policies leading to new orders exceeding 1 million yuan within two days [2] - The strategic shift towards overseas production and domestic market expansion reflects the resilience and transformation logic of Chinese manufacturing [2][3] Group 1: Strategic Adjustments - The company has established a factory in Vietnam to mitigate tariff risks, with plans for trial production by May 2025 [3] - The Vietnam factory will serve as a key point for expanding into the Southeast Asian market, creating a dual supply system with domestic bases [3] Group 2: Brand Localization - In 2020, the company acquired Skywalker Trampolines for $13 million, enhancing its brand presence in North America and shifting from an ODM/OEM model to localized brand operations [4] - This acquisition allows the company to reduce reliance on platforms like Amazon and focus on direct supply to major retailers such as Walmart and Costco [4] Group 3: Innovation and Market Focus - The company is targeting the domestic silver economy and educational equipment markets, launching new products like rehabilitation devices and smart desks [5][6] - Continuous investment in R&D, with at least 3% of revenue allocated annually, has led to 205 global patents and advancements in smart manufacturing [6] Group 4: Market Dynamics - The company is adapting to the uncertainties of the international trade environment by transitioning from passive order acceptance to actively exploring new growth avenues [7] - The focus on product innovation and brand development is aimed at enhancing profitability and market influence in response to tariff fluctuations [4][7]